Goldman Sachs Call 1200 LLY 17.05.../ DE000GG5ZQX9 /
2024-05-03 10:49:06 AM | Chg.0.000 | Bid4:50:23 PM | Ask4:50:23 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
ELI LILLY | 1,200.00 - | 2024-05-17 | Call |
GlobeNewswire
1:00 PM
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...
GlobeNewswire
05-01
H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-30
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
GlobeNewswire
04-29
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
GlobeNewswire
04-29
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
04-26
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
04-23
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire
04-22
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
GlobeNewswire
04-22
TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology...
GlobeNewswire
04-17
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
GlobeNewswire
04-15
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...
GlobeNewswire
04-10
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atop...